CoChat

Intratumoral rhIL‐12 administration in head and neck squamous cell carcinoma patients induces B cell activation

Open access
van Herpen, Carla M.L., van der Voort, Robbert, van der Laak, Jeroen A.W.M., Klasen, Ina S., de Graaf, Aniek O., van Kempen, Léon C.L., de Vries, I. Jolanda M., Boer, Tjitske Duiveman‐de, Dolstra, Harry, Torensma, Ruurd, van Krieken, Johan H., Adema, Gosse J., De Mulder, Pieter H.M. · 2008 · International Journal of Cancer
Cited by 90

The DOI matches its Crossref record.

Abstract

The objectives of this study were to investigate the effects of intratumorally (i.t.) administered recombinant human interleukin‐12 (rhIL‐12) on the distribution and function of B cells in the primary tumors, the locoregional lymph nodes and peripheral blood of head and neck squamous cell carcinoma (HNSCC) patients. The initial characterization of the patients participating in the phase Ib and phase II studies has previously been reported. After rhIL‐12 treatment, fewer secondary follicles with a broader outer region of the mantle zones and an increase in interfollicular B‐blasts were seen in the enlarged lymph nodes compared with control HNSCC patients. The size of the germinal center (GC) was diminished, partly due to a decrease in the number of CD57+ GC cells that have been associated with immune suppression. These changes did not correlate with signs of apoptosis or CXCR5 expression by B cells. Strikingly, in 3 out of 4 IL‐12 treated patients, increased IFN‐γ mRNA expression by B cells was detected. In addition, a highly significant IgG subclass switch was seen in the plasma with more IgG1, less IgG2 and more IgG4, indicating a switch to T helper 1 phenotype. Finally, peritumoral B cell infiltration was a positive prognostic sign for overall survival in the 30 HNSCC patients investigated, irrespective of IL‐12 treatment. In conclusion, these data indicate that after i.t. IL‐12 treatment in HNSCC, significant activation of the B cell and the B cell compartment occurred and that the presence of tumor infiltrating B cells correlated with overall survival of HNSCC patients. © 2008 Wiley‐Liss, Inc.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ijc.23756

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 90

Metadata

Authors
van Herpen, C. M. L., van der Voort, R., van der Laak, J. A. W. M., Klasen, I. S., de Graaf, A. O., van Kempen, L. C. L., de Vries, I. J. M., Boer, T. D., Dolstra, H., Torensma, R., van Krieken, J. H., Adema, G. J., & De Mulder, P. H. M.
Venue
International Journal of Cancer
Publisher
Wiley
Published
2008-09-12
Volume
123
Issue
10
Pages
2354-2361
ISSN
  • 0020-7136 (ISSN-L)
  • 1097-0215
OpenAlex
W2051121992
Cited by
90
References
0
FWCI
3.34
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Intratumoral rhIL‐12 administration in head and neck squamous cell carcinoma patients induces B cell activation. https://app.cochat.ai/papers/10.1002/ijc.23756
The paper
van Herpen, C. M. L., van der Voort, R., van der Laak, J. A. W. M., Klasen, I. S., de Graaf, A. O., van Kempen, L. C. L., de Vries, I. J. M., Boer, T. D., Dolstra, H., Torensma, R., van Krieken, J. H., Adema, G. J., & De Mulder, P. H. M. (2008). Intratumoral rhIL‐12 administration in head and neck squamous cell carcinoma patients induces B cell activation. International Journal of Cancer. https://doi.org/10.1002/ijc.23756

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.